InMode Ltd.
General Information | |
Business: |
We are a leading global provider of innovative, energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. Within the global aesthetics market, our products and solutions are primarily designed to address three energy-based treatment categories comprised of: (i) face and body contouring; (ii) medical aesthetics; and (iii) women’s health. We have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. |
Industry: | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
Employees: | 209 |
Founded: | 2008 |
Contact Information | |
Address | Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel |
Phone Number | +972-4-9096313 |
Web Address | http://www.inmodemd.com |
View Prospectus: | InMode Ltd. |
Financial Information | |
Market Cap | $447.6mil |
Revenues | $109.8 mil (last 12 months) |
Net Income | $26.1 mil (last 12 months) |
IPO Profile | |
Symbol | INMD |
Exchange | NASDAQ |
Shares (millions): | 5.0 |
Price range | $14.00 - $14.00 |
Est. $ Volume | $70.0 mil |
Manager / Joint Managers | Barclays/ UBS Investment Bank/ Canaccord Genuity |
CO-Managers | Baird |
Expected To Trade: | 8/8/2019 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |